| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: DNA Viruses |
Department of Tumor Virology, Institute for Genetic Medicine, Hokkaido University, N15 W7, Kita-ku, 060-8638 Sapporo, Japan1
Second Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan2
Author for correspondence: Kenzo Takada. Fax +81 11 717 1128. e-mail kentaka{at}med.hokudai.ac.jp
To quantitatively evaluate the role of Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in immortalization of peripheral B-lymphocytes, we used the Akata cell system to generate an EBV recombinant in which the first exon of the LMP2A gene was disrupted. The results indicated that deletion of the LMP2A gene did not affect the immortalization efficiency of EBV in B-lymphocytes. Deletion of the LMP2A gene made EBV-transformed lymphocytes more permissive for virus replication in response to surface immunoglobulin cross-linking. On the other hand Akata cells, in which LMP2A expression was much lower than in EBV-transformed lymphocytes, were equally permissive for virus replication whether they were infected with wild EBV or LMP2A-knockout EBV. The results raise a question as to the role of LMP2A in inhibition of disruption of virus latency in vivo, where LMP2A expression has been expected to be low as in Akata cells.
This article has been cited by other articles:
|
|
 |
|
  L. J. Anderson and R. Longnecker EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway J. Gen. Virol., July 1, 2008; 89(7): 1563 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Rechsteiner, C. Berger, L. Zauner, J. A. Sigrist, M. Weber, R. Longnecker, M. Bernasconi, and D. Nadal Latent Membrane Protein 2B Regulates Susceptibility to Induction of Lytic Epstein-Barr Virus Infection J. Virol., February 15, 2008; 82(4): 1739 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Rechsteiner, C. Berger, M. Weber, J. A. Sigrist, D. Nadal, and M. Bernasconi Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells J. Gen. Virol., May 1, 2007; 88(5): 1454 - 1459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schaadt, B. Baier, J. Mautner, G. W. Bornkamm, and B. Adler Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation J. Gen. Virol., March 1, 2005; 86(3): 551 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stewart, C. W. Dawson, K. Takada, J. Curnow, C. A. Moody, J. W. Sixbey, and L. S. Young Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-{kappa}B transcription factor pathway PNAS, November 2, 2004; 101(44): 15730 - 15735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yang, M. Hakoda, K. Iwabuchi, T. Takeda, T. Koike, N. Kamatani, and K. Takada Rheumatoid Factors Induce Signaling from B Cells, Leading to Epstein-Barr Virus and B-Cell Activation J. Virol., September 15, 2004; 78(18): 9918 - 9923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Iwakiri and K. Takada Phosphatidylinositol 3-Kinase Is a Determinant of Responsiveness to B Cell Antigen Receptor-Mediated Epstein-Barr Virus Activation J. Immunol., February 1, 2004; 172(3): 1561 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Gordadze, D. Poston, and P. D. Ling The EBNA2 Polyproline Region Is Dispensable for Epstein-Barr Virus-Mediated Immortalization Maintenance J. Virol., June 14, 2002; 76(14): 7349 - 7355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Lynch, J. S. Zimmerman, and D. T. Rowe Epstein-Barr virus latent membrane protein 2B (LMP2B) co-localizes with LMP2A in perinuclear regions in transiently transfected cells J. Gen. Virol., May 1, 2002; 83(5): 1025 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Speck, M. Ikeda, A. Ikeda, H. M. Lederman, and R. Longnecker Signal Transduction through the B Cell Antigen Receptor Is Normal in Ataxia-Telangiectasia B Lymphocytes J. Biol. Chem., February 1, 2002; 277(6): 4123 - 4127. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
